New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

Background Bellmunt Risk Score, based on Eastern Cooperative Oncology Group (ECOG) performance status (PS), hemoglobin levels and presence of liver metastases, is the most established prognostic algorithm for patients with advanced urothelial cancer (aUC) progressing after platinum-based chemotherap...

Full description

Bibliographic Details
Main Authors: Ernest Choy, Yohann Loriot, Fabio Calabrò, Cora N Sternberg, Guillermo De Velasco, Daniel Castellano, Roubini Zakopoulou, Aristotelis Bamias, Nicholas James, Axel Merseburger, F Lopez-Rios, Mario Kramer, Kimon Tzannis
Format: Article
Language:English
Published: BMJ Publishing Group 2023-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/1/e005977.full

Internet

https://jitc.bmj.com/content/11/1/e005977.full

Similar Items